Accounting for Biological Assets: Routledge Focus on Business and Management
Autor Rute Gonçalves, Patrícia Lopesen Limba Engleză Paperback – 30 iun 2021
Identifying the firm and country-level drivers that inform the disclosure and measurement practices of biological assets, this concise guide examines the value relevance of measuring those assets at fair value. It also analyses how firm and country-level drivers explain the differences in the disclosure level and practices used to measure biological assets under IAS 41. Finally, it evaluates whether there is a difference in the relevance of biological assets among the listed firms with high and low disclosure levels on biological assets.
Based on a major international study of a wide selection of firms and country-level drivers, this book is vital for standard setters, stakeholders, students, accountants and auditors who need to understand disclosure and measurement practices of biological assets under IAS 41.
Toate formatele și edițiile | Preț | Express |
---|---|---|
Paperback (1) | 195.09 lei 6-8 săpt. | |
Taylor & Francis – 30 iun 2021 | 195.09 lei 6-8 săpt. | |
Hardback (1) | 412.79 lei 6-8 săpt. | |
Taylor & Francis – 11 oct 2017 | 412.79 lei 6-8 săpt. |
Din seria Routledge Focus on Business and Management
- Preț: 400.32 lei
- 8% Preț: 416.47 lei
- Preț: 355.76 lei
- Preț: 245.32 lei
- Preț: 155.43 lei
- Preț: 389.49 lei
- Preț: 144.22 lei
- Preț: 152.76 lei
- Preț: 155.43 lei
- Preț: 377.37 lei
- Preț: 152.38 lei
- Preț: 378.81 lei
- Preț: 155.43 lei
- Preț: 386.35 lei
- Preț: 384.11 lei
- Preț: 153.62 lei
- Preț: 354.62 lei
- Preț: 153.41 lei
- Preț: 386.21 lei
- Preț: 384.29 lei
- Preț: 383.46 lei
- Preț: 355.76 lei
- Preț: 385.18 lei
- Preț: 251.09 lei
- Preț: 384.25 lei
- Preț: 385.96 lei
- Preț: 378.08 lei
- Preț: 155.43 lei
- Preț: 155.43 lei
- Preț: 269.66 lei
- Preț: 377.83 lei
- Preț: 386.75 lei
- Preț: 385.15 lei
- Preț: 153.57 lei
- Preț: 385.81 lei
- Preț: 355.76 lei
- Preț: 151.89 lei
- Preț: 153.37 lei
- Preț: 152.99 lei
- Preț: 354.68 lei
- Preț: 151.66 lei
- Preț: 384.44 lei
- Preț: 252.90 lei
Preț: 195.09 lei
Nou
Puncte Express: 293
Preț estimativ în valută:
37.35€ • 38.90$ • 30.99£
37.35€ • 38.90$ • 30.99£
Carte tipărită la comandă
Livrare economică 13-27 februarie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9781032096223
ISBN-10: 1032096225
Pagini: 118
Dimensiuni: 138 x 216 x 8 mm
Greutate: 0.45 kg
Ediția:1
Editura: Taylor & Francis
Colecția Routledge
Seria Routledge Focus on Business and Management
Locul publicării:Oxford, United Kingdom
ISBN-10: 1032096225
Pagini: 118
Dimensiuni: 138 x 216 x 8 mm
Greutate: 0.45 kg
Ediția:1
Editura: Taylor & Francis
Colecția Routledge
Seria Routledge Focus on Business and Management
Locul publicării:Oxford, United Kingdom
Public țintă
PostgraduateCuprins
Table of contents
Part I Overview
Part II International Accounting Standard 41 Agriculture
Part III Accounting for biological assets – current debate
Part IV Fair value relevance of biological assets
Part V Empirical evidence
Part VI Main findings and future avenues of research
Part I Overview
Part II International Accounting Standard 41 Agriculture
Part III Accounting for biological assets – current debate
Part IV Fair value relevance of biological assets
Part V Empirical evidence
Part VI Main findings and future avenues of research
Notă biografică
Rute Gonçalves is Accounting Supervisor at Centrar, S.A. RAR Group, Portugal. She has previously taught at the University of Porto, Portugal.
Patrícia Teixeira Lopes is Associate Dean at Porto Business School, Portugal. She was a research member of INTACCT, a European project on the application of the IAS/IFRS in Member States of the European Union.
Patrícia Teixeira Lopes is Associate Dean at Porto Business School, Portugal. She was a research member of INTACCT, a European project on the application of the IAS/IFRS in Member States of the European Union.
Descriere
This book explores accounting for biological assets under IAS 41 – Agriculture, and explains the recent adjustments introduced by the IASB which allow firms to choose between cost or revaluation models concerning mature bearer plants. Identifying the firm and country-level drivers that explain disclosure and measurement practices of biological a